Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 5
2005 7
2006 5
2007 7
2008 12
2009 14
2010 9
2011 7
2012 15
2013 12
2014 16
2015 12
2016 19
2017 24
2018 13
2019 22
2020 19
2021 30
2022 26
2023 23
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hee sung kim (160 results)?
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. Among authors: kim hs. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz JE, Okamoto A, Moore K, Kridelka F, McNeish I, Reuss A, Votan B, du Bois A, Mahner S, Ray-Coquard I, Kohn EC, Berek JS, Tan DSP, Colombo N, Zang R, Concin N, O'Donnell D, Rauh-Hain A, Herrington CS, Marth C, Poveda A, Fujiwara K, Stuart GCE, Oza AM, Bookman MA; participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research. Vergote I, et al. Lancet Oncol. 2022 Aug;23(8):e374-e384. doi: 10.1016/S1470-2045(22)00139-5. Lancet Oncol. 2022. PMID: 35901833 Free PMC article. Review.
Ovarian cancer.
Song YS, Kim HS, Aoki D, Dhanasekaran DN, Tsang BK. Song YS, et al. Among authors: kim hs. Biomed Res Int. 2014;2014:764323. doi: 10.1155/2014/764323. Epub 2014 Dec 21. Biomed Res Int. 2014. PMID: 25587539 Free PMC article. No abstract available.
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Oaknin A, Monk BJ, Vergote I, Cristina de Melo A, Kim YM, Lisyanskaya AS, Samouëlian V, Kim HS, Gotovkin EA, Damian F, Chang CL, Takahashi S, Li J, Mathias M, Fury MG, Ivanescu C, Reaney M, LaFontaine PR, Lowy I, Harnett J, Chen CI, Tewari KS. Oaknin A, et al. Among authors: kim hs. Eur J Cancer. 2022 Oct;174:299-309. doi: 10.1016/j.ejca.2022.03.016. Epub 2022 Jul 31. Eur J Cancer. 2022. PMID: 35922251 Free article. Clinical Trial.
Tumor evolution and chemoresistance in ovarian cancer.
Kim S, Han Y, Kim SI, Kim HS, Kim SJ, Song YS. Kim S, et al. Among authors: kim hs. NPJ Precis Oncol. 2018 Sep 17;2:20. doi: 10.1038/s41698-018-0063-0. eCollection 2018. NPJ Precis Oncol. 2018. PMID: 30246154 Free PMC article. Review.
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4.
Kim YN, Park B, Kim JW, Kim BG, Kim SW, Kim HS, Choi CH, Lim MC, Yl Ngoi N, Sp Tan D, Lee JY. Kim YN, et al. Among authors: kim hs. Nat Commun. 2023 Sep 6;14(1):5476. doi: 10.1038/s41467-023-40829-2. Nat Commun. 2023. PMID: 37673858 Free PMC article. Clinical Trial.
Surgical management of recurrent ovarian cancer.
Suh DH, Kim HS, Chang SJ, Bristow RE. Suh DH, et al. Among authors: kim hs. Gynecol Oncol. 2016 Aug;142(2):357-67. doi: 10.1016/j.ygyno.2016.04.537. Epub 2016 May 10. Gynecol Oncol. 2016. PMID: 27130407 Review.
278 results